University of Karachi
Also known as: BMSI, JPMC,KARACHI | CBSCR , ICCBS, University of Karachi | CBSCR, ICCBS, University of Karachi | CBSCR, ICCBS, University of Karachi, Pakistan | Center for bio-equivalence, and clinical research, university of karachi | Center for bioequivalence studies and clinical reseach (CBSCR), ICCBS, University of Karachi | Center for Bioequivalence Studies and Clinical Research | Center for bio-equivalence studies and clinical research (CBSCR) | Center for Bioequivalence Studies and Clinical Research (CBSCR), HEJ Research Institute of chemistry, University of Karachi | Center for bio-equivalence studies and clinical research, ICCBS, University of Karachi | Center for bio-equivalence studies and clinical research, ICCBS, University of Karachi, Pakistan | Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi | Jpmc | NICVD Karachi | Rehman Medical institute, Pakistan | Shifa Tameer e Millat University, Islamabad, Pakistan | University of Karachi | University of Managemant and Technology, Pakistan
Highest phase reached
Phase 4
First clinical trial
Jul 11, 2012Last known activity
Apr 1, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (45 distinct, 35 trials)
Phase 4 (8 own, 0 via acquisition)
Phase 3 (6 own, 0 via acquisition)
Phase 2 (12 own, 0 via acquisition)
Phase 1 (6 own, 0 via acquisition)
Other trials (13 own, 0 via acquisition)
Indications
Studied for
Recent trials (50)
- NCT06871904CollaboratorPhase 1/Phase 2Apr 1, 2025
- NCT06479434CollaboratorN/AJun 24, 2024
- NCT06172764CollaboratorPhase 4Dec 12, 2023
- NCT05847218OfficialPhase 1Mar 9, 2023
- NCT05847218Overall official - principal investigatorPhase 1Mar 9, 2023
- NCT05847218CollaboratorPhase 1Mar 9, 2023
- NCT05599802Overall official - principal investigatorPhase 1Feb 28, 2023
- NCT05817799CollaboratorPhase 2/Phase 3Jan 1, 2023
- NCT05637060Reponsible party - principal investigatorN/ANov 24, 2022
- NCT05637060Overall official - principal investigatorN/ANov 24, 2022
- NCT05637060OfficialN/ANov 24, 2022
- NCT05637060Lead sponsorN/ANov 24, 2022
- NCT05637060Sponsor investigatorN/ANov 24, 2022
- NCT05573958CollaboratorPhase 4Oct 1, 2022
- NCT07089446Sponsor investigatorN/ASep 21, 2022
Details
- Last known activity
- Apr 1, 2025